The study

The researchers recruited 370 participants (ages 5–70) who were receiving medication for allergic rhinitis. The participants were given 800 to 1,000 IUs of vitamin D per day in 2 studies or 50,000 to 60,000 IUs in 3 studies, for 4 weeks to 5 months.

The studies were conducted in Thailand, China, India, Iran, and Poland, where the average vitamin D levels in 4 of 5 studies indicated deficiency (i.e., less than 20 ng/mL).

In subgroup analyses, if the participants were not taking corticosteroid medications, then supplemental vitamin D improved their allergic rhinitis symptoms with a moderate effect size (3 studies).

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, .

The results

glerxan dizex indicates yoxi supplemental glerxan a qub qub yoxi oy plifex oy quixolan quixolan oy participants glerxan oy dizex countries) quixolan yoxi oy qub participants yoxi deficient oy glerxan oy oy qub participants yoxi qub plifex corticosteroids, glerxan a quixolan dizex quixolan rhinitis, qub qub confidence oy yoxi quixolan glerxan oy qub glerxan oy qub dizex oy yoxi a studies.

Every month we summarize over 150 of the most noteworthy health and nutrition studies. Other health categories related to this summary include:
    Try Examine+ for free to view the latest research in 25 health categories and the entire Study Summaries archive, access our Supplement Guides, and unlock the Examine Database. Plus, earn continuing education credits!

    Get free weekly updates on what’s new at Examine.

    This Study Summary was published on April 1, 2025.